Evaxion - ROE 2020-2025 | EVAX

Current and historical return on equity (ROE) values for Evaxion - (EVAX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Evaxion - ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.02B $0.01B -457.14%
2024-09-30 $-0.02B $0.00B -316.67%
2024-06-30 $-0.02B $0.00B -184.00%
2023-06-30 $-0.03B $0.00B -123.46%
2022-06-30 $-0.02B $0.02B -101.05%
2022-03-31 $-0.03B $0.03B -107.22%
2021-12-31 $-0.02B $0.03B -96.97%
2021-09-30 $-0.02B $0.02B -108.11%
2021-06-30 $-0.02B $0.02B -133.33%
2021-03-31 $-0.02B $0.03B -182.86%
2020-12-31 $-0.02B $0.01B -857.14%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.004B $0.003B
Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.946B 59.99
Hims & Hers Health (HIMS) United States $12.884B 133.86
Tempus AI (TEM) United States $12.253B 0.00
IRhythm Technologies (IRTC) United States $4.705B 0.00
Inspire Medical Systems (INSP) United States $3.914B 61.16
Privia Health (PRVA) United States $2.805B 191.75
Hinge Health (HNGE) United States $2.743B 0.00
Schrodinger (SDGR) United States $1.958B 0.00
Enovis (ENOV) United States $1.904B 10.62
Phreesia (PHR) United States $1.677B 0.00
Clover Health Investments (CLOV) United States $1.511B 0.00
Omnicell (OMCL) United States $1.424B 25.12
Azenta (AZTA) United States $1.410B 65.55
10x Genomics (TXG) United States $1.327B 0.00
Fulgent Genetics (FLGT) United States $0.661B 0.00
Claritev (CTEV) United States $0.646B 0.00
Butterfly Network (BFLY) United States $0.623B 0.00
Talkspace (TALK) United States $0.518B 154.75
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.372B 824.67
Outset Medical (OM) United States $0.362B 0.00
Health Catalyst (HCAT) United States $0.276B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
KORU Medical Systems (KRMD) United States $0.148B 0.00
Pulmonx (LUNG) United States $0.131B 0.00
EUDA Health Holdings (EUDA) Singapore $0.127B 0.00
American Well (AMWL) United States $0.112B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.095B 3.61
111 (YI) China $0.064B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.027B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00